Skip to content

Transcriptomics 101 (cancer)

Transcriptomics measures RNA abundance and isoform usage. In tumors it reveals pathway activity, immune infiltration, and drug-response signatures.

Bulk RNA-seq

  • Count matrix: genes × samples after alignment and quantification
  • DE analysis: tumor vs normal, treatment arms, molecular subtypes
  • Gene signatures: proliferation, hypoxia, immune scores — often used in trials and biomarker work

Single-cell and spatial

For heterogeneity and microanatomy, see Intro to single-cell and spatial.

Clinical angles

  • Fusion transcripts (some assays are DNA; some are RNA-first)
  • Immune repertoire and checkpoint-related expression patterns
  • Companion diagnostics sometimes use expression (see Biomarkers)

See also

Early public release. Content evolves through continuous review. Questions: [email protected] · CC BY 4.0 where applicable.